EconomyEXCLUSIVE: ‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says
A senior source close to the matter told Reuters that AstraZeneca and Bristol Myers Squibb are not engaged in discussions about a possible deal. The statement effectively shuts down speculation about a potential mega merger between the two drugmakers. The source’s comments reject the prospect of ongoing negotiations between the companies.
R
Reuters★★☆☆☆2026-08-05 13:50Original
EXCLUSIVE: ‘No discussions’ over AstraZeneca-Bristol Myers deal, senior source says
Economy